FORENSIC TOXICOLOGY

LABORATORY METHODS | RESEARCH EXPLAINED

CBD-to-THC Conversion During GC-MS Sample Preparation

The short answer: A laboratory can change a compound before the instrument measures it. Andrews and Paterson demonstrated that a particular acidic derivatization procedure produced matching retention times and mass spectra from separately prepared CBD and THC standards. The finding concerns the preparation method they studied. It does not establish that every THC test mistakes CBD for THC.

What happens before the instrument matters

Gas chromatography-mass spectrometry, or GC-MS, combines separation with mass-spectral information. Some methods first use derivatization: a chemical reaction that changes the target compound into a form suitable for analysis. The instrument then measures the resulting derivative, not necessarily the original, unchanged molecule.

That distinction creates an important question. Did the preparation preserve information that distinguishes the substances of interest, or did the chemistry make different starting compounds look alike? An instrument result cannot answer that question without information about the preceding chemistry.

What the 2012 experiment demonstrated

In their 2012 technical note in the Journal of Analytical Toxicology, Rebecca Andrews and Sue Paterson compared THC and CBD after two preparation approaches. One used trifluoroacetic anhydride with hexafluoroisopropanol, abbreviated TFAA-HFIP. The other produced trimethylsilyl derivatives using MSTFA.

With TFAA-HFIP, the separately prepared THC and CBD standards generated the same three-peak chromatographic pattern, with matching retention times and corresponding mass spectra. The authors explained the result through acid-promoted conversion of CBD to THC and further formation of related products. Their trimethylsilyl derivatives did not show that same loss of distinction.

The experiment therefore identified a specific selectivity problem. Agreement with the expected retention time and spectrum could be misleading if the preparation converted an alternative starting substance into the same measured products.

Why this is not a claim that all cannabis testing fails

The paper studied particular reagents and laboratory conditions. A finding about TFAA-HFIP cannot simply be assigned to a different preparation procedure, a different target analyte, or an LC-MS/MS assay. Nor does this laboratory experiment establish that CBD converts to THC inside a person.

The result also does not supply a universal correction factor. It cannot tell a reviewer how much, if any, of a particular reported THC concentration came from CBD. That requires case-specific method information and appropriate experimental evidence. A possible interference and a demonstrated interference in the tested specimen are different conclusions.

Records that make the question answerable

The following are practical review questions derived from the study, not a claim that every laboratory uses the affected procedure:

  1. Identify the reported analyte. Was the laboratory reporting parent THC, a metabolite, CBD, or several cannabinoids? Obtain the full method rather than relying on the report’s abbreviated test name.
  2. Identify the preparation chemistry. Request the method version, derivatizing reagents, reaction conditions, and any modifications used for the actual batch.
  3. Examine selectivity experiments. Ask whether CBD-containing material was processed through the complete procedure and whether it produced a reportable THC signal under the laboratory’s criteria.
  4. Review more than the final concentration. Obtain the chromatograms, mass-spectral identification information, reference-standard runs, blanks, and relevant batch records.
  5. Distinguish repetition from an independent approach. Repeating the same preparation may reproduce the same chemical transformation. Ask whether a suitable alternative method addresses the identified source of ambiguity.

What a defensible conclusion sounds like

A narrow conclusion might be that the available records do not yet establish whether the laboratory’s preparation distinguishes CBD from THC. A stronger conclusion requires evidence that the relevant chemistry and identification problem occurred under the conditions at issue. Neither conclusion, by itself, establishes impairment, exposure timing, or the composition of a consumed product.

For the broader record-review framework, see Laboratory Results and Analytical Methods. For additional technical background, the related educational library explains derivatization for GC-MS and analytical selectivity.

Primary source and scope

Andrews R, Paterson S. Production of Identical Retention Times and Mass Spectra for Delta-9-Tetrahydrocannabinol and Cannabidiol Following Derivatization with Trifluoracetic Anhydride with 1,1,1,3,3,3-Hexafluoroisopropanol. Journal of Analytical Toxicology. 2012;36(1):61-65. doi:10.1093/jat/bkr017.

AI-assisted educational literature summary prepared for this website from the cited paper. No article-specific independent expert review is asserted. This is not a case opinion, medical advice, or a determination that any particular laboratory result is wrong. See our scientific standards and editorial policy.